TI
SMTI icon

Trexquant Investment’s Sanara MedTech SMTI Stock Holding History

Trexquant Investment’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+9,413
New +$195K ﹤0.01% 1788

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Trexquant Investment's SMTI Position: Q2 2026 in Review

Trexquant Investment opened a new position in Sanara MedTech (SMTI) in Q2 2026: 9,413 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1788 among its holdings.

75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Trexquant Investment held 9,413 shares of Sanara MedTech worth $222K as of Q2 2026.
  • Sanara MedTech was a new Trexquant Investment position in Q2 2026.
  • Sanara MedTech made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1788 holding.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.